CMS Proposes International Pricing Index Model for Medicare Part B Drugs

CMS has issued an Advance Notice of proposed rulemaking regarding the development of a potential model that seeks payment prices comparable for Part B drugs relative to other economically-similar countries. CMS says that a proposed rule would be issued, based on comments, in the spring of 2019. Further, if adopted, the model would become effective in the spring of 2020 and would run for 5 years. The intent of the model is to reduce drug spending. CMS estimates that the proposal would reduce Medicare spending by $17.2 billion over the 5-year duration of the model. For more details, see today’s Financial Feature.

Visit Us

North Carolina Healthcare Association

2400 Weston Parkway
Cary, NC 27513

Main: 919-677-2400
Fax: 919-677-4200

Contact Us